Status:
UNKNOWN
Role of Healthy Bacteria in Ulcerative Colitis
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Collaborating Sponsors:
Ministry of Science and Technology, India
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Intestinal inflammation seen in inflammatory bowel disease (IBD) results from an altered mucosal immune response to luminal bacterial antigens. Current research suggests that an inappropriate and pers...
Eligibility Criteria
Inclusion
- Age between 18 and 65 years
- Active disease at presentation
Exclusion
- Pregnant or lactating women
- Any patient who has received probiotic in the preceding 4 weeks
- Patient with life threatening cardiac, renal, pulmonary or cardiovascular disease
- Inability to obtain the informed consent
- Severe disease requiring hospitalization / steroids/ anti-cytokine therapy
- Patient taking aspirin and other antiplatelet drugs
- Patient with uncontrolled diabetes
- Patient with Gall stone disease
- Patient currently on antibiotic,NSAIDs or indigenous medicine
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2014
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01479660
Start Date
March 1 2011
End Date
October 1 2014
Last Update
November 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Post Graduate Institute of Medical Education and Research
Chandigarh, Chandigarh, India, 160012